Real-time enrollment status for this metastatic castration-resistant prostate cancer clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 10:44 AM UTC
| NCT Number | NCT07365995 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castration-resistant Prostate Cancer |
| Phase | PHASE3 |
| Target Enrollment | 736 participants |
| Active Locations | 15 sites in the US |
| Sponsor | BioNTech SE |
| Last Updated on CT.gov | July 20, 2026 (Jul 20, 2026) |
As of August 27, 2026: Clinical trial NCT07365995 is currently recruiting participants. This phase3 study for metastatic castration-resistant prostate cancer is actively seeking new participants at 15 locations across the United States. The study is sponsored by BioNTech SE. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07365995 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07365995 was last updated Jul 20, 2026 (July 20, 2026). HelloStudys verifies this status automatically.